← Back to Search

Prevention Strategies for HIV Among At-risk Latinos

N/A
Waitlist Available
Led By Laura R Glasman
Research Sponsored by Medical College of Wisconsin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Cis-gender female.
Did not have sex with men or identify as homosexual or bisexual.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up past 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing if a network intervention can help Latino men who have sex with men and transwomen get regular HIV tests and prevent HIV transmission.

Who is the study for?
This trial is for Latino men who have sex with men and transwomen over 18 years old, living in Milwaukee, Cleveland, or Indianapolis. Participants must be able to consent and belong to a network where at least 80% are of Latinx descent. Cisgender females and those not identifying as homosexual or bisexual cannot join.
What is being tested?
The study tests the effectiveness of HIV prevention strategies among friendship networks through regular testing, risk reduction counseling, PrEP awareness, and referrals. It's a randomized controlled trial comparing these interventions within selected communities.
What are the potential side effects?
Since this trial focuses on counseling and education rather than medication or medical procedures, there may not be direct physical side effects; however participants might experience emotional distress or anxiety related to discussing personal behaviors associated with HIV risk.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am a cisgender female.
Select...
I do not identify as homosexual or bisexual nor have sex with men.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~past 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and past 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mean percentage of PrEP-eligible participants who report having consulted with a provider about PrEP.
Mean percentage of participants who report having had unprotected sex with a casual partner.
Mean percentage of participants who report having tested for HIV in the past 6 months.
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Standard of Care plus Network InterventionExperimental Treatment2 Interventions
Network intervention
Group II: Standard of CareActive Control1 Intervention
HIV counseling and testing
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HIV counseling and testing
2012
N/A
~490

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,918 Previous Clinical Trials
2,739,509 Total Patients Enrolled
Medical College of WisconsinLead Sponsor
631 Previous Clinical Trials
1,181,500 Total Patients Enrolled
Laura R GlasmanPrincipal InvestigatorMedical College of Wisconsin

Media Library

HIV counseling and testing Clinical Trial Eligibility Overview. Trial Name: NCT04563715 — N/A
Human Immunodeficiency Virus Infection Research Study Groups: Standard of Care, Standard of Care plus Network Intervention
Human Immunodeficiency Virus Infection Clinical Trial 2023: HIV counseling and testing Highlights & Side Effects. Trial Name: NCT04563715 — N/A
HIV counseling and testing 2023 Treatment Timeline for Medical Study. Trial Name: NCT04563715 — N/A
~91 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top